Literature DB >> 12390918

Reduced lung function both before bronchiolitis and at 11 years.

S W Turner1, S Young, L I Landau, P N Le Souëf.   

Abstract

BACKGROUND AND AIMS: We have previously shown an association between reduced premorbid lung function (V'maxFRC) and bronchiolitis. We hypothesised that individuals with bronchiolitis will go on to have reduced lung function and increased respiratory symptoms in childhood.
METHODS: V'maxFRC was measured at 1 month of age; individuals with bronchiolitis were prospectively identified. Annual symptom questionnaires were completed from 3 to 6 years. At 11 years of age, children underwent an assessment including questionnaire, lung function, airway response to histamine (AR), and skin prick testing.
RESULTS: Eighteen individuals with bronchiolitis were ascertained from 253 cohort members. Children with bronchiolitis had increased viral induced wheeze at 3 (OR 5.8, 95% CI 1.4 to 25.2; n = 103) and 5 years (OR 5.3, 95% CI 1.1 to 25.5; n = 101). At 11 years of age, 194 children were assessed including 16 with past bronchiolitis. These 16 individuals had reduced mean z scores for % V'maxFRC compared with other children (-0.56 and 0.06 respectively) and mean z scores for % FEF(25-75) at 11 years (-0.53 and 0.06 respectively). At 11 years, FEV(1), FVC PEF, AR, atopy, wheeze, and diagnosed asthma were not different between groups.
CONCLUSIONS: Reduced lung function is present before and after bronchiolitis; the level of reduction is comparable. The mechanism for wheeze and reduced lung function after bronchiolitis appears to be related to premorbid lung function and not bronchiolitis per se.

Entities:  

Mesh:

Year:  2002        PMID: 12390918      PMCID: PMC1763101          DOI: 10.1136/adc.87.5.417

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

Review 1.  Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link.

Authors:  N Sigurs
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

2.  Predictors of asthma three years after hospital admission for wheezing in infancy.

Authors:  T M Reijonen; A Kotaniemi-Syrjänen; K Korhonen; M Korppi
Journal:  Pediatrics       Date:  2000-12       Impact factor: 7.124

3.  Relationship between bronchial hyperresponsiveness and development of asthma in wheezy infants.

Authors:  R Saga; H Mochizuki; K Tokuyama; A Morikawa
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

4.  Alterations in airway wall properties in infants with a history of wheezing disorders.

Authors:  U Frey; K Makkonen; T Wellman; C Beardsmore; M Silverman
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

5.  Analysis of dose-response curves to methacholine. An approach suitable for population studies.

Authors:  G O'Connor; D Sparrow; D Taylor; M Segal; S Weiss
Journal:  Am Rev Respir Dis       Date:  1987-12

6.  Rapid method for measurement of bronchial responsiveness.

Authors:  K Yan; C Salome; A J Woolcock
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

7.  Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy.

Authors:  C R Pullan; E N Hey
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-05

8.  Parental factors affecting respiratory function during the first year of life.

Authors:  S Young; D L Sherrill; J Arnott; D Diepeveen; P N LeSouëf; L I Landau
Journal:  Pediatr Pulmonol       Date:  2000-05

9.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

Authors:  R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

10.  Outcome of acute lower respiratory tract infection in infants: preliminary report of seven-year follow-up study.

Authors:  J Y Mok; H Simpson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31
View more
  14 in total

Review 1.  Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma.

Authors:  Amy S Feldman; Yuan He; Martin L Moore; Marc B Hershenson; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

2.  Exploring the origins of asthma: Lessons from twin studies.

Authors:  Simon Francis Thomsen
Journal:  Eur Clin Respir J       Date:  2014-09-01

Review 3.  Acute bronchiolitis.

Authors:  Andrew Bush; Anne H Thomson
Journal:  BMJ       Date:  2007-11-17

Review 4.  Lung functional development and asthma trajectories.

Authors:  Fabienne Decrue; Olga Gorlanova; Jakob Usemann; Urs Frey
Journal:  Semin Immunopathol       Date:  2020-01-27       Impact factor: 9.623

5.  Genes associated with RSV lower respiratory tract infection and asthma: the application of genetic epidemiological methods to understand causality.

Authors:  Emma K Larkin; Tina V Hartert
Journal:  Future Virol       Date:  2015-07       Impact factor: 1.831

6.  Clinical trials research in pediatrics: strategies for effective collaboration between investigator sites and the pharmaceutical industry.

Authors:  Andrew Bush
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

7.  Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants.

Authors:  S Broughton; A Roberts; G Fox; E Pollina; M Zuckerman; S Chaudhry; A Greenough
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

Review 8.  Management of paediatric asthma.

Authors:  J Grigg
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

Review 9.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

10.  Lung function of preterm infants before and after viral infections.

Authors:  Simon B Drysdale; Jessica Lo; Michael Prendergast; Mireia Alcazar; Theresa Wilson; Mark Zuckerman; Melvyn Smith; Simon Broughton; Gerrard F Rafferty; Janet L Peacock; Sebastian L Johnston; Anne Greenough
Journal:  Eur J Pediatr       Date:  2014-06-06       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.